Shots: AstraZeneca is collaborating with multiple countries and multilateral organizations to make the University of Oxford’s vaccine widely accessible across the globe in an equitable manner. AstraZeneca has received its first agreement for ~400M doses with a manufacturing capacity of 1B doses and anticipated first delivery in Sept’2020 BARDA has granted ~$1B to support the […]Read More
Tags : ChAdOx1 nCoV-19 Vaccine
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US